Follow the Sunshine Lake Pharma Co., Ltd. - H Shares stock price and the full directors' dealings record of the company, a listed issuer based in Hong Kong. Shares are listed on the HK market, under the authority of HKEX. Market capitalisation: €42.2bn. The latest transaction was disclosed on 3 August 2026 (Purchase). Among the most active insiders: zhang yushuai. The full history is free.
18
Insider Decl.
n/a
Thresholds
€12m
13 ops.
Buy Volume
n/a
5 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Sunshine Lake Pharma Co., Ltd. - H Shares Buy (bullish), based on 5 analysts. Average price target: HK$4.50.
27Σ signal
Buys €12mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 2,897 of 28,716 companies
73.8
score / 100
Value
89
Quality
59
FCF yld·
Earn yld16%
EV/EBITDA6.3x
ROE10%
Gross mgn·
Net mgn8.1%
Debt/EBITDA2.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Sunshine Lake Pharma Co., Ltd. is a pharmaceutical company focused on the development and commercialization of drugs. It is listed as H shares on the stock market.